Showing results (41-50 of 87) with videos related to
Sort By:
Pageof 9
Cell Reports|July 19, 2018
HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss VariantsAndrew Nguyen, Louisa Ho, Samuel T Workenhe, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2007
On the role of CD4+ T cells in the CD8+ T-cell response elicited by recombinant adenovirus vaccinesTeng Chih Yang, James Millar, Timothy Groves, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 30, 2009
Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunityJeanette E Boudreau, Byram W Bridle, Kyle B Stephenson, et al.Cancers|February 25, 2023
Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory CellsMaria Eugenia Davola, Olga Cormier, Alyssa Vito, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2011
Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccinesJennifer D Bassett, Stephanie L Swift, Heather VanSeggelen, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
CTL-dependent and -independent antitumor immunity is determined by the tumor not the vaccineJaina Leitch, Katie Fraser, Cecilia Lane, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2023
HDACi-dependent Microenvironmental Normalization Overcomes Tumor Burden-induced T-cell ExhaustionAndrew Nguyen, Dominique Brown, Ramya Krishnan, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2005
Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterpartsJanet I Malowany, Sarah McCormick, Michael Santosuosso, et al.The Journal of Clinical Investigation|November 5, 2019
Endogenous T cells prevent tumor immune escape following adoptive T cell therapyScott R Walsh, Boris Simovic, Lan Chen, et al.The Journal of Clinical Investigation|November 14, 2018
Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicityScott R Walsh, Donald Bastin, Lan Chen, et al.Pageof 9